These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7904216)

  • 41. A special population: nursing diagnoses for the psychiatric client with mental retardation.
    Hochberger JM
    Arch Psychiatr Nurs; 1993 Oct; 7(5):308-10. PubMed ID: 8257200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a psychopathology rating scale for children with mental retardation.
    Reiss S; Valenti-Hein D
    J Consult Clin Psychol; 1994 Feb; 62(1):28-33. PubMed ID: 8034825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities.
    Aman MG
    Ann Clin Psychiatry; 1993 Sep; 5(3):171-88. PubMed ID: 7904217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of psychotropic medications for persons with mental retardation who live in Oklahoma nursing homes.
    Spreat S; Conroy J
    Psychiatr Serv; 1998 Apr; 49(4):510-2. PubMed ID: 9550242
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mental retardation and psychiatric illness.
    Vitiello B; Behar D
    Hosp Community Psychiatry; 1992 May; 43(5):494-9. PubMed ID: 1587514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormalities of chromosome 18 in a girl with mental retardation and autistic disorder.
    Ghaziuddin M; Sheldon S; Tsai LY; Alessi N
    J Intellect Disabil Res; 1993 Jun; 37 ( Pt 3)():313-7. PubMed ID: 8334323
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency and severity of challenging behaviour in people with profound intellectual and multiple disabilities.
    Poppes P; van der Putten AJ; Vlaskamp C
    Res Dev Disabil; 2010; 31(6):1269-75. PubMed ID: 20728304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional properties of behaviour problems depending on level of intellectual disability.
    Medeiros K; Rojahn J; Moore LL; van Ingen DJ
    J Intellect Disabil Res; 2014 Feb; 58(2):151-61. PubMed ID: 23464786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenging behaviours should not be considered as depressive equivalents in individuals with intellectual disability.
    Tsiouris JA; Mann R; Patti PJ; Sturmey P
    J Intellect Disabil Res; 2003 Jan; 47(Pt 1):14-21. PubMed ID: 12558691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of DSM and ICD diagnostic criteria in people with mental retardation. A review of empirical studies.
    Sturmey P
    J Nerv Ment Dis; 1993 Jan; 181(1):38-41. PubMed ID: 8419513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychiatric illness among the mentally retarded. A swedish population study.
    Göstason R
    Acta Psychiatr Scand Suppl; 1985; 318():1-117. PubMed ID: 3893045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. RETRACTED: Questions About Behavioral Function (QABF): adaptation and validation of the Spanish version.
    Simó-Pinatella D; Alomar-Kurz E; Font-Roura J; Giné C; Matson JL; Cifre I
    Res Dev Disabil; 2013 Apr; 34(4):1248-55. PubMed ID: 23417130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Adolescent Behavior Checklist: normative data and sensitivity and specificity of a screening tool for diagnosable psychiatric disorders in adolescents with mental retardation and other development disabilities.
    Demb HB; Brier N; Huron R; Tomor E
    Res Dev Disabil; 1994; 15(2):151-65. PubMed ID: 8085031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Barnhill LJ; Davis JM
    J Clin Psychiatry; 2003 Oct; 64(10):1258-65. PubMed ID: 14658977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Aberrant Behavior Checklist and the Behavior Problems Inventory: convergent and divergent validity.
    Rojahn J; Aman MG; Matson JL; Mayville E
    Res Dev Disabil; 2003; 24(5):391-404. PubMed ID: 12951135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Individuals with Smith-Magenis syndrome display profound neurodevelopmental behavioral deficiencies and exhibit food-related behaviors equivalent to Prader-Willi syndrome.
    Alaimo JT; Barton LV; Mullegama SV; Wills RD; Foster RH; Elsea SH
    Res Dev Disabil; 2015 Dec; 47():27-38. PubMed ID: 26323055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diverse diagnostic and behavioural patterns amongst people with a dual diagnosis.
    Dudley JR; Ahlgrim-Delzell L; Calhoun ML
    J Intellect Disabil Res; 1999 Apr; 43 ( Pt 2)():70-9. PubMed ID: 10221786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risperidone for aggression and self-injurious behavior in adults with mental retardation.
    Cohen SA; Ihrig K; Lott RS; Kerrick JM
    J Autism Dev Disord; 1998 Jun; 28(3):229-33. PubMed ID: 9656134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hidden psychiatric morbidity in a vocational programme for people with intellectual disability.
    Salvador-Carulla L; Rodríguez-Blázquez C; Rodríguez de Molina M; Pérez-Marín J; Velázquez R
    J Intellect Disabil Res; 2000 Apr; 44 ( Pt 2)():147-54. PubMed ID: 10898378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
    Bodfish JW; Madison JT
    Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.